Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Patient Centered Research. We strive to find innovative medicines that provide value to patients, physicians and healthcare systems. We have two marketed products approved in Europe and other territories BrinavessTM (vernakalant IV), for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults and Aggrastat® a reversible GP IIb/IIIa inhibitor for use in Acute Coronary Syndrome patients. Investor Information Cardiome is traded on the NASDAQ Capital Market (CRME) and the Toronto Stock Exchange (COM).
View Top Employees from Cardiome Pharma CorpWebsite | https://www.cardiome.com |
Ticker | FRA:72R |
Revenue | $25.3 million |
Employees | 43 (15 on RocketReach) |
Founded | 1986 |
Address | 1441 Creekside Dr. 6th Fl, Vancouver, British Columbia V6J 4S7, CA |
Phone | (604) 677-6905 |
Fax | (604) 677-6915 |
Technologies | |
Industry | Biotechnology, Healthcare, Biopharma, Cardiology Drug Discovery and Development, Pharmaceuticals, Drug Manufacturing & Research, Health Care, Science and Engineering |
Web Rank | 27 Million |
Keywords | Cardiome Pharma Corp |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Cardiome Pharma Corp employee's phone or email?
The Cardiome Pharma Corp annual revenue was $25.3 million in 2023.
Donald McAfee is the Chief Scientific Officer of Cardiome Pharma Corp.
15 people are employed at Cardiome Pharma Corp.
Cardiome Pharma Corp is based in Vancouver, British Columbia.
The NAICS codes for Cardiome Pharma Corp are [32541, 5417, 54, 32, 541, 3254, 325].
The SIC codes for Cardiome Pharma Corp are [28, 283].